We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




CACLP Announces New Date and Venue for the Highly Anticipated 2025 Event

By LabMedica International staff writers
Posted on 14 Oct 2024
Print article
Image: In March 2024, the tradeshow was a resounding success, showcasing a diverse array of products and technologies from participants.
Image: In March 2024, the tradeshow was a resounding success, showcasing a diverse array of products and technologies from participants.

Impressive numbers from CACLP 2024
In March 2024, the tradeshows were a resounding success, showcasing a diverse array of products and technologies from participants. The events drew an impressive 1,346 exhibitors and 42,751 visitors from China and 40 other countries, all gathered in a sprawling exhibition space of 130,000 sqm.

A series of academic activities featured 125 scientific lectures with 315 academic speakers and attracted over 5,000 delegates. These activities garnered 462,150 online views through CACLP’s WeChat channels and app.

Hangzhou: the ideal host for CACLP 2025
The upcoming event will return to Hangzhou, offering global participants a convenient and enriching experience in the newly opened Hangzhou Grand Convention & Exhibition Center.

Located in the heart of the economically vibrant Yangtze River Delta, Hangzhou offers convenient transportation, advanced innovation, and abundant natural and cultural resources. This enchanting city provides an ideal environment for the IVD industry. There are 6,626 medical and healthcare institutions in Hangzhou, including 414 hospitals and 27 top-tier (Grade A, Level 3) hospitals. Hangzhou has also pioneered China’s first dedicated IVD industry promotion institute to bolster local industry development. 

With China’s favorable visa-free policy, international participants will find it easier than ever to join, and discover an optimal setting for collaboration, extensive networking, and exploration of the latest market trends and innovations. 

Academic Highlights in Hangzhou
Numerous professionals across the whole IVD industry chain are expected take part in the concurrent academic activities, such as the 10th China Experimental Medicine Conference (CEMC) and series sessions and the 12th China IVD Industry Development Conference (CIIDC) and series forums.

These activities will include in-depth discussions on hot topics in laboratory medicine and IVD, with renowned experts and scholars presenting cutting-edge research findings, while industry leaders exchange valuable experiences.

 "Bringing IVD people together!" embodies our commitment to always foster unity and progress within the industry. Join us in Hangzhou for CACLP 2025!

Interested in exhibiting or seeking more information? Leave your message here and we will get back to you very soon: https://en.caclp.com/exhibit-reserve.html


About GL events
GL events is a world-class leading provider of integrated solutions and services for events operating across the 3 major core divisions: Venues (venue management), Exhibitions (exhibition organizing) and Live (event services).
Through its wide global network made up of more than 90 offices, with organizing over 480 proprietary trade fair and events, managing more than 60 venues, and staging more than 4,200 events every year, GL events Group is a critical force for city promotion of 28 MICE destinations.
Present on five continents with operations in more than 20 countries, GL events has over 5,119 employees. Listed on the Eurolist Euronext Compartment B (Paris Stock Exchange), GL events had a turnover of €1.315bn in 2022.

About CACLP
Debut launched in 1991, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. China IVD Supply Chain Expo, successfully launched in 2021, further expands the product sectors from upstream to downstream. With a great number of high-level academic and educational programs held concurrently onsite, and year-round promotional solutions, CACLP proves itself as one of the most important platforms for global IVD players.
In 2020, CACLP formed the joint-venture company with GL events to start the internationalism strategy.

 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.